Aprea Therapeutics Share Price (NASDAQ: APRE)
$1.56
Last updated on
Check the interactive Aprea Therapeutics Stock chart to analyse performance
Aprea Therapeutics stock performance
as on August 30, 2025 at 1:27 am IST
- Today's Low:$1.55Today's High:$1.60
0.64%
Downside
Day's Volatility :3.13%
Upside
2.5%
- 52 Weeks Low:$1.4152 Weeks High:$5.01
9.49%
Downside
52 Weeks Volatility :71.82%
Upside
68.86%
Aprea Therapeutics Stock Returns
Aprea Therapeutics Inc Key Stats
Check Aprea Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Aprea Therapeutics Stock including INR - Dollar returns
The Aprea Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Aprea Therapeutics investment value today
Current value as on today
₹50,765
Returns
Returns from Aprea Therapeutics Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Aprea Therapeutics Stock
Global Institutional Holdings in Aprea Therapeutics Inc
Name
Holdings %
AIGH Capital Management, LLC
9.38%
Sio Capital Management, LLC
4.86%
Sphera Funds Management Ltd.
4.69%
Nantahala Capital Management, LLC
3.58%
Vanguard Group Inc
3.02%
Dafna Capital Management LLC
2.38%
Analyst Recommendation on Aprea Therapeutics Stock
Buy
88%Buy
11%Hold
0%Sell
Based on 9 Wall street analysts offering stock ratings for Aprea Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Aprea Therapeutics Share Price Target
What analysts predicted
Upside of 573.08%
Target:
$10.50
Current:
$1.56
Aprea Therapeutics share price target is $10.50, a slight Upside of 573.08% compared to current price of $1.56 as per analysts' prediction.
Aprea Therapeutics Stock Insights
Price Movement
In the last 6 months, APRE stock has moved down by -38.0%APRE vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 124.1%APRE vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 202.7%Price to Sales
ForAPRE every $1 of sales, investors are willing to pay $11.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Aprea Therapeutics Technicals Summary
Sell
Neutral
Buy
Aprea Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Aprea Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -7.65% | -32.03% | -52.85% | -89.94% | -99.7% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 0.48 | NA | NA | -0.67 | -0.68 | -0.39 | NA | 2.33 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $9.2M | -99.7% | 0.48 | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Aprea Therapeutics Inc
Key Management of Aprea Therapeutics Inc
Important FAQs about investing in APRE Stock from India :
What is Aprea Therapeutics share price today?
Aprea Therapeutics share price today is $1.56 as on at the close of the market. Aprea Therapeutics share today touched a day high of $1.60 and a low of $1.55.
What is the 52 week high and 52 week low for Aprea Therapeutics share?
Aprea Therapeutics share touched a 52 week high of $5.01 and a 52 week low of $1.41. Aprea Therapeutics stock price today i.e. is closed at $1.56, lower by 68.86% versus the 52 week high.
How to invest in Aprea Therapeutics Stock (APRE) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Aprea Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aprea Therapeutics Shares that will get you 0.9615 shares as per Aprea Therapeutics share price of $1.56 per share as on August 30, 2025 at 1:27 am IST.
What is the minimum amount required to buy Aprea Therapeutics Stock (APRE) from India?
Indian investors can start investing in Aprea Therapeutics (APRE) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Aprea Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Aprea Therapeutics share’s latest price of $1.56 as on August 30, 2025 at 1:27 am IST, you will get 6.4103 shares of Aprea Therapeutics. Learn more about
fractional shares .
What are the returns that Aprea Therapeutics has given to Indian investors in the last 5 years?
Aprea Therapeutics stock has given -99.7% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%